SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-098661
Filing Date
2023-12-26
Accepted
2023-12-26 17:26:15
Documents
15
Period of Report
2023-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea190663-8k_aditxtinc.htm   iXBRL 8-K 45130
2 SERIES A-1 CERTIFICATE OF DESIGNATIONS FILED WITH THE SECRETARY OF STATE OF DELA ea190663ex3-1_aditxtinc.htm EX-3.1 296289
3 EXCHANGE AGREEMENT, DATED DECEMBER 22, 2023 BY AND BETWEEN THE COMPANY AND THE H ea190663ex10-1_aditxtinc.htm EX-10.1 207808
4 REGISTRATION RIGHTS AGREEMENT, DATED DECEMBER 22, 2023 BY AND BETWEEN THE COMPAN ea190663ex10-2_aditxtinc.htm EX-10.2 178479
  Complete submission text file 0001213900-23-098661.txt   1083351

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adtx-20231222.xsd EX-101.SCH 3009
6 XBRL LABEL FILE adtx-20231222_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE adtx-20231222_pre.xml EX-101.PRE 22355
9 EXTRACTED XBRL INSTANCE DOCUMENT ea190663-8k_aditxtinc_htm.xml XML 3494
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 231514186
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)